Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Study Design:
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Incl. Criteria Patients with clinical diagnosis of stable Chronic Obstructive Pulmonary Disease (COPD) according to definition of China COPD guideline.
Patients over 40 years old
You may not be if
Patient with history of hypersensitivity to tiotropium bromide, atropine and/or its derivant, i.e. ipratropium, or any component of Spiriva® Patient with known narrow-angle glaucoma
Patient with known symptomatic prostatic hyperplasia and/or bladder-neck obstruction
Patient with known moderate to severe renal impairment (i.e.,creatinin clearance\<=50ml/min)
Pregnant or nursing women
Patient with any significant disease other than COPD which would exclude him/her from participating in the study
Patients with any conditions listed in \[special precautions\], \[drug interactions\], and \[contraindication\] of Spiriva® China package insert
Patients with signed informed consent of any other study
Clareo Health | Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities
